1133820-08-2

Upstream product

• 32017-77-9 2-(m-methoxyphenyl)oxirane 
• 123-08-0 4-hydroxy-benzaldehyde 
• 626-20-0 3-methoxystyrene 

Downstream Products

• 1133820-09-3 5-{4-[2-hydroxy-2-(3-methoxyphenyl)ethoxy]benzylidene}-1,3-thiazolidine-2,4-dione 
• 1133820-10-6 5-[[4-[2-(3-methoxyphenyl)-2-hydroxyethoxy]phenyl]methyl]-2,4-thiazolidinedione 
• 1133819-87-0 5-[[4-[2-(3-methoxyphenyl)-2-oxoethoxy]phenyl]methyl]-2,4-thiazolidinedione 

Relevant academic research and scientific papers

PPAR-sparing thiazolidinedione salts for the treatment of metabolic diseases

The present invention relates to novel salts of thiazolidinediones and other pharmaceutical agents that are useful for treating and/or preventing metabolic diseases (e.g., diabetes, or neurodegenerative diseases (e.g., Alzheimer's Disease).

PPAR-SPARING THIAZOLIDINEDIONES AND COMBINATIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

The present invention relates to PPARy- sparing compounds and pharmaceutical compositions formulated with such compounds that are useful for treating, delaying the onset of, or reducing the symptoms of a neurodegenerative disorder including Huntington's disease, epilepsy, AMS, and MS.

THIAZOLIDINEDIONE ANALOGUES

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. In other aspects, the present invention also presents methods of treating hypertension, diabetes, or other inflamm

THIAZOLIDINEDIONE ANALOGUES FOR THE TREATMENT OF HYPERTENSION

The present invention relates to thiazolidinedione analogues that are useful for treating hypertension, diabetes, and inflammatory diseases. Formula (I), wherein: each of R1 and R4 is independently selected from H, halo, aliphatic, a